SCHEMBL2655815

SCHEMBL2655815

Cc1nc(CC2CCCCC2)no1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 1/20 0.41
ALDH1A1 P00352 5/20 0.40
RAB9A P51151 2/20 0.40
TSHR P16473 1/20 0.39
RECQL P46063 1/20 0.39
KDM4E B2RXH2 3/20 0.37
HRH4 Q9H3N8 1/20 0.37
NPC1 O15118 1/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 2/20 0.36
HSD11B1 P28845 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
GAA P10253 1/20 0.34
PDE8B O95263 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16364797 0.98 OPRL1 (0.39) OPRL1ALDH1A1RAB9ATSHRRECQL
SCHEMBL16364796 0.94 KDM4E (0.38) OPRL1ALDH1A1RAB9AKDM4EKMT2A
SCHEMBL13211439 0.90 ALDH1A1 (0.42) ALDH1A1RAB9AKDM4ENPC1KMT2A
SCHEMBL18168051 0.82 GBA1 (0.37) ALDH1A1KDM4EHRH4KMT2ALMNA
Hydrochloric Acid SCHEMBL16400653 0.81 LMNA (0.36) ALDH1A1KDM4EHRH4KMT2ALMNA
SCHEMBL21359440 0.80 EED (0.43) OPRL1HRH4KMT2ALMNA
SCHEMBL18977431 0.80 ALDH1A1 (0.36) ALDH1A1KDM4EKMT2ALMNAHSD11B1
SCHEMBL17918747 0.78 LMNA (0.33) ALDH1A1KDM4EKMT2ALMNA
SCHEMBL18977652 0.78 TSHR (0.42) OPRL1ALDH1A1RAB9ATSHRRECQL
SCHEMBL15479746 0.77 BMP1 (0.40) OPRL1ALDH1A1RAB9ATSHRRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2703392-B1 5-MEMBERED RING AROMATIC HETEROCYCLIC DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY SHIONOGI & CO (JP) 2017-06-14 EP disclosed
US-8916594-B2 5-membered ring heteroaromatic derivatives having NPY Y5 receptor antagonistic activity SHIONOGI & CO., LTD. (JP) 2014-12-23 US disclosed
US-7196106-B2 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK & CO., INC (US) 2007-03-27 US disclosed
US-7196106-B2 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK & CO., INC (US) 2007-03-27 US disclosed
US-20040097552-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. 2004-05-20 US disclosed
US-20040097552-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. 2004-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097552-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use GLP1R, GPR119, GCGR OPRL1 502/4885ALDH1A1 2652/4885RAB9A 4713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.